Blog

Alexandre Chan: Electroacupuncture Regimens Compared in Breast Cancer Survivors – Randomized Controlled Trial

Alexandre Chan/LinkedIn

Jun 2, 2025, 08:17

Alexandre Chan: Electroacupuncture Regimens Compared in Breast Cancer Survivors – Randomized Controlled Trial

Alexandre Chan, Founding Chair and Professor of Clinical Pharmacy Practice at UCI School of Pharmacy and Pharmaceutical Sciences, posted on LinkedIn:

“Let’s meet up if you are attending ASCO25.

I will be in Poster Hall A (Board 139) on Monday (6/2) afternooon 1-4pm to present our UC Irvine RCT on Electroacunpuncture and Integrative Oncology approaches to improve complex symptoms and brain structures in breast cancer survivors. See you there!”

Title: Comparison of two electroacupuncture regimens on symptoms and brain structures in breast cancer survivors: A randomized, controlled trial.

Authors: Alexandre Chan, Olivia Grace Georgina Drayson, Ding Quan Ng, Matthew Heshmatipour, Julia Trudeau, Sayeh Moazami Lavasani, Ritesh Parajuli, Sanghoon Lee, Lifang Xie, Munjal Acharya, Charles Limoli, Shaista Malik

Read The Full Article.

Alexandre Chan: Electroacupuncture Regimens Compared in Breast Cancer Survivors - Randomized Controlled Trial

More posts featuring ASCO25.

Alexandre Chan cancer Charles Limoli Ding Quan Ng Julia Trudeau Lifang Xie Matthew Heshmatipour Munjal Acharya Olivia Grace Georgina Drayson OncoDaily Oncology Ritesh Parajuli Sanghoon Lee Sayeh Moazami Lavasani Shaista Malik

BEATcc Trial at ESMOGynaec25: Atezolizumab Benefits Cervical Cancer Patients Regardless of PD-L1 Status

15 Posts Not to Miss from EACR 2025

ASCO 2025 RCC Advances: Expert Insights by Ilya Tsimafeyeu

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself